The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hypofractionated, accelerated radiotherapy to the prostate bed: Five-year outcomes of a prospective phase I/II study.
 
Kevin Martell
No Relationships to Disclose
 
Patrick Cheung
No Relationships to Disclose
 
Gerard Morton
Honoraria - Abbvie; AstraZeneca; Elekta
 
Hans T. Chung
Honoraria - Sanofi; Tersera
Consulting or Advisory Role - Elekta
 
Andrea Deabreu
No Relationships to Disclose
 
Liying Zhang
No Relationships to Disclose
 
Geordi Pang
No Relationships to Disclose
 
Yasir Alayed
No Relationships to Disclose
 
Alexandre Mamedov
No Relationships to Disclose
 
Adam Gladwish
No Relationships to Disclose
 
Andrew Loblaw
Honoraria - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb (I); Ferring; GlaxoSmithKline (I); Janssen Oncology; Merck (I); Novartis (I); Roche (I)
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb (I); Ferring; GlaxoSmithKline (I); Janssen Oncology; Merck (I); Novartis (I); Roche (I)
Patents, Royalties, Other Intellectual Property - Prostate immobilization device (GU-Lok)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Janssen Oncology